Navigation Links
Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer

of further pre-clinical and clinical trials; obtaining, maintaining and protecting intellectual property utilized by our products; our ability to enforce our patents against infringers and to defend our patent portfolio against challenges from third parties; our ability to obtain additional funding to support our business activities; our dependence on third parties for development, manufacture, marketing, sales, and distribution of products; the successful development of our product candidates, all of which are in early stages of development; obtaining regulatory approval for products; competition from others using technology similar to ours and others developing products for similar uses; our dependence on collaborators; and our short operating history; as well as those risks more fully discussed in the "Risk Factors" section of our most recent report on Form 10-K on file with the Securities and Exchange Commission. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. We do not assume any obligation to update any forward-looking statements.

Contact

Alnylam Pharmaceuticals, Inc.
Cynthia Clayton (Investors)
617-551-8207
or
KMorrisPR
Kathryn Morris (Media)
845-635-9828


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus
2. Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study

Post Your Comments:
(Date:11/6/2009)... Facet Solutions, Inc. announced today that it has... The acquisition creates an undisputed leadership ...ty and clinical experience in posterior motion pre...rom lumbar spinal stenosis," stated Facet Solution...idation further strengthens Facet Solutions, posit...
(Date:11/6/2009)... Philips Respironics applauds the efforts of the C... raise awareness about an important public health ...lease of the first-ever government study to monito... milestone in quantifying the size and scope of th...y leader and sleep therapy manufacturer, Philips R...
(Date:11/6/2009)...Newswire/ -- Chimerix, Inc., a biopharmaceutical c...eutics to address life-threatening diseases, prese...ead antiviral compound, CMX001, to the World Healt...y Initiative (GHSI). CMX001 is a broad-spectrum a...f smallpox, as well as other serious viral infecti...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Simple measures may prevent transmission of stomach ulcer bacteria 49935 1West Coast needs more research on fisheries marine science climate change 8987 1West Coast needs more research on fisheries marine science climate change 8987 2First Ever Egg Donor Web Portal Becomes One of The Largest Resources for Aspiring Parents in the U S 12769 1First Ever Egg Donor Web Portal Becomes One of The Largest Resources for Aspiring Parents in the U S 12769 2
...c. (Nasdaq: CADX ), a biopharmaceutical company f...ing proprietary product candidates principally,for...cial results for the,third quarter and nine months...ided an update on the clinical development,program...avance(TM), an,intravenous formulation of acetamin...
...Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharm...nced top-line results from its Phase 1 clinical,tr...ts with solid tumors,showing that picoplatin achie... given by the oral route. The results demonstrated...as linear at doses below 200 mg, and that,maximum ...
Other Medicine Technology:Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 2Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 3Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 4Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 5Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 6Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 7Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 8Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin 2Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin 3Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin 4
(Date:11/8/2009)...-USNewswire/ -- The American Public Health Associa...rovisions in the health reform bill passed last ni..., the House takes important steps toward universal...and moving our health system from one that focuses...ng people healthy," said Georges C. Benjamin, MD, ...
(Date:11/8/2009)...ealth Care Reform Bill ,, Critical legislatio...all Americans ,, HARRISBURG, Penn., Nov. 8 /PR...ht the United States House of Representatives pass...uld strengthen Medicare for seniors and end discri...ns of Americans out of affordable health coverage....
(Date:11/8/2009)...otes self-assurance, research finds , , ... have been right when she told you to sit up strai... make you feel more confident about your thoughts....aight gives a good impression to other people," Ri...gy professor at Ohio State University, said in a u...
(Date:11/8/2009)...of Health holds open house at Victoria campus , ...er 8, 2009 -- UCW Academy of Health invites anyone...uo;s health care industry to attend their open hou... ,UCW Academy of Health, which offers diplomas in ...ervices, designs its programs to meet the needs of...
(Date:11/8/2009)...the game later, doctors say , , SUNDAY, ...alk of the NFL this season, sidelining such stars ... Parker. , Officials at the American Podiatric ...ric Sports Medicine are warning athletes to take c...football and lacrosse. , "Many fall sports athl...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:Good Posture May Inspire Confidence 2Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Rx for Fall Foot Injuries 2
...itute of Mental Health currently conducting a stud...tment for Body Dysmorphic Disorder. Hollywood isn...eveloping into a crisis. BDD is similar to other ... New York, NY (PRWEB) August 2, 2008 -- In an ...
...for,Disease Control and Prevention,s (CDC) long an...HIV infections will be revealed on Aug. 3 in a pap...l Association (JAMA). The,revised estimated number...006 will replace the current, widely reported,esti...
...,(Nasdaq: GXDX ), a specialized laboratory servic...am and Laurence R. McCarthy, Ph.D. to its Board of...tham has been elected to,serve as a Class I direct...en elected to serve as a Class II director of,Geno...
... of cell death improves cancer therapy efficacy ,...one of the most aggressive types of brain tumor, h...ical studies indicated therapeutics inhibiting a g...ted clinical success only a small proportion of p...
...nt and anticipation. It also can be a time of anxi...abetes. Pregnancy in women who have diabetes is au...to-read booklet has information to help women with...information about checking and controlling blood g...
... neurodegenerative diseases, study says , ...dence that the adult human brain has the ability t...nd Clinic Lerner Research Institute. , The study i... surround and protect nerves. When the myelin is d...
Other Medicine News:Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 2Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 3Health News:Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy 2Health News:Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy 3Health News:Genoptix Announces the Addition of New Members to Board of Directors 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 3Health News:JCI online early table of contents: Aug. 1, 2008 2Health News:JCI online early table of contents: Aug. 1, 2008 3Health News:JCI online early table of contents: Aug. 1, 2008 4Health News:JCI online early table of contents: Aug. 1, 2008 5Health News:JCI online early table of contents: Aug. 1, 2008 6Health News:JCI online early table of contents: Aug. 1, 2008 7Health News:Neurons Can Re-Grow in Some MS Lesions 2
...lades are designed with the clinician in mind. The...to simplify cleaning - no crevices or hard to reac...crews that can be misplaced. The bright focused bl...ber optic systems manufactured to ISO 7376-3. Trad...
...lades are designed with the clinician in mind. The...to simplify cleaning - no crevices or hard to reac...crews that can be misplaced. The bright focused bl...ber optic systems manufactured to ISO 7376-3. Trad...
Fiberoptic Green System Blade Miller Oxiport
...of the vocal cords in even the most difficult case...e a standard laryngoscope, Viewmax® does not r...tage lies in its ability to allow intubation wheth...irway. It has a patented lens system that refracts...
Medicine Products: